54734-81-5

Basic information

• Product Name: Benzenesulfonamide, 2-amino-4-bromo-
• CAS NO: 54734-81-5
• Molecular Formula: C6H7BrN2O2S
• Molecular Weight: 251.104
• Mol File: 54734-81-5.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, 2-amino-4-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 2-amino-4-bromo-(54734-81-5)
• EPA Substance Registry System: Benzenesulfonamide, 2-amino-4-bromo-(54734-81-5)

Safety Data

• Hazardous Substances Data: 54734-81-5(Hazardous Substances Data)

Upstream product

• 364-73-8 4-Bromo-1-fluoro-2-nitrobenzene 
• 875-51-4 4-Bromo-2-nitroaniline 
• 89581-41-9 4-bromo-2-nitrobenzenesulfonamide 

Downstream Products

• 1357259-44-9 C₄₃H₄₅N₇O₇S 
• 1357259-46-1 C₄₈H₅₄N₈O₈S 
• 1357258-67-3 C₄₅H₄₈N₈O₈S 
• 1357259-43-8 C₁₉H₁₈BrN₃O₄S 
• 1612855-02-3 C₅₀H₆₁N₉O₈S 
• 1612853-95-8 C₅₁H₆₂N₈O₈S 
• 1560648-26-1 C₁₉H₁₈BrN₃O₄S 
• 1446139-35-0 C₄₄H₅₂N₈O₈S 
• 1446139-34-9 C₄₃H₄₄N₆O₆S 
• 240140-18-5 2-amino-4-(pyridin-3-yl)-benzenesulfonamide 
• 240138-60-7 3-Cyclohexyl-6-(pyridin-3-yl)-1,2,3,4-tetrahydro-1,2,4-benzothiadiazine-1,1-dioxide 
• 240139-76-8 2-amino-4-(2-methoxyphenyl)-benzenesulfonamide 
• 240138-56-1 3-Cyclohexyl-6-(2-methoxyphenyl)-1,2,3,4-tetrahydro-1,2,4-benzothiadiazine-1,1-dioxide 
• 80938-51-8 6-(aminomethyl)-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide 

Relevant articles and documents

Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.

BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Provided herein is a compound of formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof, which can also be used for treating HCV infection or a HCV disorder.

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R' have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors,in HCV therapy.